NightWare Launches Campaign to Disrupt Nightmares FDA-Cleared Digital Therapeutic Treats PTSD Nightmares Minneapolis, MN (December 4, 2024) – NightWare, the manufacturer of the FDA-cleared digital therapeutic device that treats PTSD-related nightmares, announced today that is has launched an equity crowdfunding campaign on StartEngine. The NightWare device is a dedicated non-invasive medical device using an AI algorithm that identifies when a …